Richard W Yee, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease (NCT05995392) | Richard W Yee, MD | 2023-08-01 |
| The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease (NCT04792580) | Richard W Yee, MD | 2022-10-22 |
Track Richard W Yee, MD automatically
Every clearance here is in the API, with alerts when new ones post.